Town Sports International Holdings, Inc. (“TSI” or the “Company”)
(NASDAQ:CLUB), today announced that Daniel Gallagher has been appointed
Chief Executive Officer and Robert Giardina has been appointed Executive
Chairman of the Board.
GFI Board Unanimously Recommends Stockholders Tender Their Shares to BGC's Offer Offer Set to Expire on February 26 with no Further Extensions Expected
Accepted Shares Expected to be Paid for on March 3, 2015 NEW YORK , Feb.
Q4 2014 revenue of $30.9 million – second highest in company history – a 5% year-over-year increase from Q4 2013 Delivered year-over-year quarterly revenue growth for the first time in 2 years Q4 2014 adjusted EBITDA of $4.0 million – the highest in company history – a 44% year-over-year increase from Q4 2013 Full Year 2014 revenue of $106.6 million, beating guidance of $100M - $103M Full Year 2014 adjusted EBITDA of $2.2 million, beating guidance of ($0.5)M - $0.5M
BUFFALO, N.Y., Feb.
bluebird bio, Inc. (Nasdaq: BLUE), a clinical-stage company committed to
developing potentially transformative gene therapies for severe genetic
and rare diseases and T cell-based immunotherapies, today reported
business highlights and financial results for the fourth quarter and
full year ended December 31, 2014.
~ Total Sales of $16.6 Million for Q4 and $75.0 Million for Full-Year 2014 ~~ Full Year Sales Growth at 4%, 6% in Constant Currency ~~ Over 500,000 Visian® ICLs™ Successfully Implanted
~~ Q4 GAAP Net Loss of $0.07 per Share, Non-GAAP Net Loss of $0.03 MONROVIA, Calif.
MIDLAND PARK, NJ--(Marketwired - February 25, 2015) - Stewardship Financial Corporation (NASDAQ: SSFN), parent company of Atlantic Stewardship Bank, today announced results for the fourth quarter and full year ended December 31, 2014.
The board of directors of Cigna Corporation (NYSE: CI) today declared a
cash dividend of $0.04 per share of Cigna common stock, payable on April
10, 2015, to shareholders of record as of the close of business on March
Principal Financial Group, Inc. (NYSE: PFG) announced that its board of
directors has approved an authorization for the repurchase of up to $150
million worth of the company’s outstanding common stock.
Completed Two Tenapanor Phase 2b Clinical Trials in Patients with Constipation-Predominant Irritable Bowel Syndrome (IBS-C) and in Chronic Kidney Disease Patients with Hyperphosphatemia (CKD-5D)
Phase 2a Data for Tenapanor in CKD Patients Expected in 2Q 2015 Conference Call and Webcast Today at 4:30 p.m. ET FREMONT, Calif.
Sign-up for Solar Capital Ltd. Announces Quarter and Fiscal Year Ended December 31, 2014 Financial Results; Declares Quarterly Dividend of $0.40 Per Share for First Fiscal Quarter 2015 investment picks
/PRNewswire/ -- Herman Miller , Inc. (NASDAQ: MLHR) today announced that it will participate in the Raymond James 36th Annual Institutional Investors Conference in Orlando, Florida on Wednesday, March 4 , 2015.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.